QLGN News and Press, Qualigen Therapeutics Inc. From 05/19/21

New Position Created to Deepen Clinical Expertise and Advance Pipeline Therapeutic Programs CARLSBAD, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for t...

Discovery DISCK +24% on definitive agreement with AT&T.Aerpio Pharmaceuticals ARPO +20% on merger deal with Aadi Bioscience.Nuvve Holding Corp. (NVVE) +16%.Aterian (ATER) +13%.Net Element (NETE) +13%.Mind Medicine MNMD +12% on receiving FDA Type C meeting res...

Qualigen Therapeutics (QLGN): Q1 GAAP EPS of -$0.13 beats by $0.01.Revenue of $1.9M (+111.1% Y/Y) beats by $0.7M.As of March 31, 2021, Qualigen Therapeutics had $21.9 million of cash and cash equivalents.Press Release For further details see: Qualigen Therapeutics EPS beats by $0.01, be...

Conference call scheduled for May 18, 2021 at 4:10 p.m. EDT. Revenues Increased 30 Percent to $1.9 Million Compared to $1.5 Million in the Same Quarter of the Previous Year On Track to File an IND in 2H21 for Treating Hospitalized COVID-19 Patients with QN-165 Completed the ...

Qualigen Therapeutics Inc. (NASDAQ:QLGN) traded today at a new 52-week low of $1.77. So far today approximately 1.3 million shares have been exchanged, as compared to an average 30-day volume of 892,000 shares. Qualigen Therapeutics Inc is a biotechnology company focused on the developme...

Shares of Qualigen Therapeutics Inc. (NASDAQ:QLGN) traded today at $1.76, breaking its 52-week low. Approximately 1.3 million shares have changed hands today, as compared to an average 30-day volume of 892,000 shares. Qualigen Therapeutics Inc. (NASDAQ:QLGN) has potential upside of 46.3%...

Qualigen Therapeutics Inc. (NASDAQ:QLGN) traded today at a new 52-week low of $2.02. Approximately 1.3 million shares have changed hands today, as compared to an average 30-day volume of 892,000 shares. In the past 52 weeks, Qualigen Therapeutics Inc. share prices are bracketed by a curr...

Shares of Qualigen Therapeutics Inc. (NASDAQ:QLGN) traded at a new 52-week low today of $2.01. This new low was reached on above average trading volume as 1.3 million shares traded hands, while the average 30-day volume is approximately 892,000 shares. Potential upside of 25.1% exists fo...

Shares of Qualigen Therapeutics Inc. (NASDAQ:QLGN) traded at a new 52-week low today of $1.93. This new low was reached on above average trading volume as 1.3 million shares traded hands, while the average 30-day volume is approximately 892,000 shares. Qualigen Therapeutics Inc is a biot...

iRhythm Technologies (IRTC) -30% after Novitas publishes updated reimbursement rates.Qualigen Therapeutics (QLGN) -18% after it pulls marketing application for COVID-19 test.Gulf Resources (GURE) -11% on correcting and replacing - Q4 & FY2020 financial result...